Clinical trial results, published in The Journal of Neuroscienceby Eli Lilly & Co., suggest a promising new therapy for Alzheimer's disease.
Read More
University Medical Center nears top safety grade, looks to improve in November
By Michael Racz | 4 days agoIn the spring 2026 Leapfrog Hospital Safety Grades, the University Medical Center received a “B” grade — the second-highest grade awarded by The Leapfrog Group — with a numerical score of 3.18, just 0.02 points below the threshold for an “A.”
U.Va. Health System Board discusses leadership turnover, telehealth initiatives across the system
By Michael Racz | 6 days agoThe Board of Visitors’ Health System Board met Thursday and discussed recent leadership changes across the Health System, presented a new set of strategic pillars and priorities and distributed information on the history and current status of U.Va. Health’s telemedicine offerings.
Dr. Sarah Flowers discusses pathology and genetic risk in Alzheimer’s disease
By Charlotte Gabriel | September 15, 2026The “U Ask, U.Va. Answers” speaker series is hosted by the Office of the Vice President for Research with the goal of presenting University research to the Charlottesville community and sparking curiosity in the public.
